Citation Impact
Citing Papers
LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses
2014
A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
2014
Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti–human DEC205 monoclonal antibody
2010 StandoutNobel
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
2010 Standout
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
2013
Cutting Edge: NKG2ChiCD57+ NK Cells Respond Specifically to Acute Infection with Cytomegalovirus and Not Epstein–Barr Virus
2014
Self-Amplifying mRNA Vaccines
2014
Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites
2017
Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation
2015 StandoutNobel
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Pathogen recognition and development of particulate vaccines: Does size matter?
2006
Autophagy during viral infection — a double-edged sword
2018
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
2007
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Viral Infection in the Renal Transplant Recipient
2005
T-bet and Eomes Are Differentially Linked to the Exhausted Phenotype of CD8+ T Cells in HIV Infection
2014
Nasopharyngeal carcinoma
2019 Standout
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Intracellular Toll-like Receptors
2010 StandoutNobel
Testing for Polyomavirus Type BK DNA in Plasma to Identify Renal-Allograft Recipients with Viral Nephropathy
2000
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Nasopharyngeal carcinoma
2015 Standout
Egr2-dependent gene expression profiling and ChIP-Seq reveal novel biologic targets in T cell anergy
2013
Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series
2020 Standout
Regulating highly dynamic unstructured proteins and their coding mRNAs
2009
Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
2013
Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity
2006
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
2020 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
LAG-3 in Cancer Immunotherapy
2010
Host Translation at the Nexus of Infection and Immunity
2012
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Infection in Solid-Organ Transplant Recipients
2007 Standout
Molecular and cellular insights into T cell exhaustion
2015 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Human T Cell Development, Localization, and Function throughout Life
2018
Breaking down the barriers to cancer immunotherapy
2005 StandoutNobel
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Diagnosis and Treatment of BK Virus-Associated Transplant Nephropathy
2007
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems
2007
Investigating Cell Surface Galectin-Mediated Cross-Linking on Glycoengineered Cells
2012 StandoutNobel
Pathways through Networks of Branched DNA
1970 StandoutScienceNobel
PD-1–PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
2008
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Concomitant Tumor Immunity and the Resistance to a Second Tumor Challenge
1983
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
2011 StandoutNobel
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells
2007
Colony Inhibition of Fibroblasts from Chimeric Dogs Mediated by the Dogs' Own Lymphocytes and Specifically Abrogated by Their Serum
1970 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
On Concomitant Immunity in Tumour-bearing Hamsters
1967 Nature
Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor
1975 StandoutNobel
Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer
2016
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice
1974 Science
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Cellular and Humoral immunity to Different Types of Human Neoplasms
1968 Nature
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
Concomitant immunity in hamsters bearing dmba‐induced tumor transplants
1969
The future of immune checkpoint therapy
2015 StandoutScienceNobel
The pathogenesis of cancer metastasis
1980 StandoutNature
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
2015
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Immunological Surveillance in Neoplasia
1971
Studies on cellular immunity and its serum‐mediated inhibition in moloney‐virus‐induced mouse sarcomas
1969
Cellular Immunity Against Tumor Antigens
1969
Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis
2016 StandoutNobel
A Certain Symmetry : Histocompatibility Antigens compared with Immunocyte Receptors
1970 Nature
The “Silent” Global Burden of Congenital Cytomegalovirus
2013
Cell-Mediated Immunity to Tumor Cells
1974
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
2012
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
When Galectins Recognize Glycans: From Biochemistry to Physiology and Back Again
2011
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
1986 StandoutNature
Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans
2012 StandoutNobel
ANTIGENIC SPECIFICITIES ON MURINE SARCOMA CELLS
1971
H–2 Antigens on a murine lymphoma are associated with additional proteins
1978 StandoutNatureNobel
Immunodepression and Malignancy
1976
Works of Corey Smith being referenced
Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition
2008
Effective Treatment of Metastatic Forms of Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
2012
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses
2004
Compartmentalization of Total and Virus-Specific Tissue-Resident Memory CD8+ T Cells in Human Lymphoid Organs
2016
Immune Regulation of Human Herpesviruses and Its Implications for Human Transplantation
2013
Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition
2016
Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases
2013
Induction of Pluripotent Protective Immunity Following Immunisation with a Chimeric Vaccine against Human Cytomegalovirus
2008
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
1984
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients
2006
Evidence for an Immunological Reaction of the Host Directed Against Its Own Actively Growing Primary Tumor<xref ref-type="fn" rid="FN1">2</xref>
1966
Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8+ T cells
2012
Galectin-1 mediated suppression of Epstein-Barr virus–specific T-cell immunity in classic Hodgkin lymphoma
2007
Functional Reversion of Antigen-Specific CD8+ T Cells from Patients with Hodgkin Lymphoma following In Vitro Stimulation with Recombinant Polyepitope
2006
Adoptive T‐cell immunotherapy for ganciclovir‐resistant CMV disease after lung transplantation
2015
Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus
2011
Acquisition of Polyfunctionality by Epstein-Barr Virus-Specific CD8 + T Cells Correlates with Increased Resistance to Galectin-1-Mediated Suppression
2009
Autophagy and proteasome interconnect to coordinate cross‐presentation through MHC class I pathway in B cells
2016